Literature DB >> 35575929

HDL and Kidney Diseases.

Huanhuan Cao1, Xia Meng2.   

Abstract

Serum lipid profiles, as well as HDL can be altered in patients with kidney diseases. There are various types of kidney diseases, including nephrotic syndrome and chronic kidney disease. In patients with nephrotic syndrome, plasma levels of HDL cholesterol and ApoA-I were within or below the normal limits. The HDL cholesterol: total cholesterol ratio decreased compared to healthy individuals. In patients with chronic kidney disease (CKD), reverse cholesterol transport function of HDL is impaired, and CKD also affects the composition and function of HDL. Cardiovascular disease (CVD) is the severe complication of CKD. Furthermore, HDL might also be a potential target for the prevention of cardiovascular complications associated with CKD.
© 2022. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Chronic kidney disease; HDL; Nephrotic syndrome

Mesh:

Substances:

Year:  2022        PMID: 35575929     DOI: 10.1007/978-981-19-1592-5_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  51 in total

Review 1.  Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future.

Authors:  Rutger J Maas; Jeroen K Deegens; Jack F Wetzels
Journal:  Nephrol Dial Transplant       Date:  2014-12       Impact factor: 5.992

Review 2.  Kidney disease and cardiovascular disease: implications of dyslipidemia.

Authors:  William F Keane; Paulette A Lyle
Journal:  Cardiol Clin       Date:  2005-08       Impact factor: 2.213

Review 3.  Nephrotic syndrome in infants and children: pathophysiology and management.

Authors:  Mallory L Downie; Claire Gallibois; Rulan S Parekh; Damien G Noone
Journal:  Paediatr Int Child Health       Date:  2017-09-15       Impact factor: 1.990

Review 4.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

Review 5.  Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature.

Authors:  V Audard; F Larousserie; P Grimbert; M Abtahi; J-J Sotto; A Delmer; F Boue; D Nochy; N Brousse; R Delarue; P Remy; P Ronco; D Sahali; P Lang; O Hermine
Journal:  Kidney Int       Date:  2006-05-03       Impact factor: 10.612

Review 6.  Cardiovascular Disease Risk in Children With Kidney Disease.

Authors:  Christine B Sethna; Kumail Merchant; Abigail Reyes
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299

7.  Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.

Authors:  Tonny H M Banh; Neesha Hussain-Shamsy; Viral Patel; Jovanka Vasilevska-Ristovska; Karlota Borges; Cathryn Sibbald; Deborah Lipszyc; Josefina Brooke; Denis Geary; Valerie Langlois; Michele Reddon; Rachel Pearl; Leo Levin; Monica Piekut; Christoph P B Licht; Seetha Radhakrishnan; Kimberly Aitken-Menezes; Elizabeth Harvey; Diane Hebert; Tino D Piscione; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

Review 8.  Nephrotic syndrome.

Authors:  David S Liebeskind
Journal:  Handb Clin Neurol       Date:  2014

Review 9.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Authors:  Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2014-03-16       Impact factor: 8.860

Review 10.  A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues.

Authors:  Takehiko Wada; Masaomi Nangaku
Journal:  Clin Kidney J       Date:  2015-09-15
View more
  1 in total

1.  Special Issue on "Advances in Cholesterol and Lipid Metabolism".

Authors:  Allison B Reiss; Joshua De Leon
Journal:  Metabolites       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.